Drug-coated Balloon Treatment
ConditionCoronary Artery Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorIstanbul Mehmet Akif Ersoy Educational and Training Hospital
About this trial
Evaluation of the efficacy and clinical outcomes of drug-eluting balloon therapy in ticyaici coronary artery disease.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
coronary artery lesions treated with drug coated balloon dilatation or drug eluting stent implantation
Trial design
Design model
Cohort
Time perspective
Retrospective
Treatments tested in this trial
drug coated balloon
Devicepatients treated with drug coated balloon dilatation
drug eluting stent
Devicepatients treated with drug eluting stent implantation
Treatment groups
1,000 Participants
are divided into 2 treatment groupsGroup A: drug coated balloon1 intervention
Group B: drug eluting stent1 intervention
Trial outcomes
Primary outcomes
1
target lesion failure
composite endpoint of target lesion revascularization, target vessel myocardial infarction and cardiac death
Time frame
12 monthSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov